ABT•benzinga•
FDA Warns of Clip Lock Malfunctions With Abbott's MitraClip Heart Valve Devices
Summary
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 9, 2022 by benzinga